Atomoxetine is commonly used to treat attention-deficit hyperactivity disorder (ADHD) in children with a broad range of cognitive abilities. We examined the association between level of cognitive functioning as determined by IQ and clinical response during treatment with atomoxetine.
Mazzone, L., Reale, L., Mannino, V., Cocuzza, M., Vitiello, B. (2011). Lower IQ is associated with decreased clinical response to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder. CNS DRUGS, 25(6), 503-509 [10.2165/11590450-000000000-00000].
Lower IQ is associated with decreased clinical response to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder
Mazzone L.
;
2011-01-01
Abstract
Atomoxetine is commonly used to treat attention-deficit hyperactivity disorder (ADHD) in children with a broad range of cognitive abilities. We examined the association between level of cognitive functioning as determined by IQ and clinical response during treatment with atomoxetine.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Lower IQ is Associated with Decreased.pdf
accesso aperto
Licenza:
Copyright dell'editore
Dimensione
196.18 kB
Formato
Adobe PDF
|
196.18 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
